Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.

BACKGROUND:Malaria in pregnancy is associated with adverse birth outcomes. However, the underlying mechanisms remain poorly understood. Tight regulation of angiogenic, metabolic, and inflammatory pathways are essential for healthy pregnancies. We hypothesized that malaria disrupts these pathways lea...

Full description

Bibliographic Details
Main Authors: Robyn E Elphinstone, Andrea M Weckman, Chloe R McDonald, Vanessa Tran, Kathleen Zhong, Mwayiwawo Madanitsa, Linda Kalilani-Phiri, Carole Khairallah, Steve M Taylor, Steven R Meshnick, Victor Mwapasa, Feiko O Ter Kuile, Andrea L Conroy, Kevin C Kain
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-10-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1002914
_version_ 1819040893289627648
author Robyn E Elphinstone
Andrea M Weckman
Chloe R McDonald
Vanessa Tran
Kathleen Zhong
Mwayiwawo Madanitsa
Linda Kalilani-Phiri
Carole Khairallah
Steve M Taylor
Steven R Meshnick
Victor Mwapasa
Feiko O Ter Kuile
Andrea L Conroy
Kevin C Kain
author_facet Robyn E Elphinstone
Andrea M Weckman
Chloe R McDonald
Vanessa Tran
Kathleen Zhong
Mwayiwawo Madanitsa
Linda Kalilani-Phiri
Carole Khairallah
Steve M Taylor
Steven R Meshnick
Victor Mwapasa
Feiko O Ter Kuile
Andrea L Conroy
Kevin C Kain
author_sort Robyn E Elphinstone
collection DOAJ
description BACKGROUND:Malaria in pregnancy is associated with adverse birth outcomes. However, the underlying mechanisms remain poorly understood. Tight regulation of angiogenic, metabolic, and inflammatory pathways are essential for healthy pregnancies. We hypothesized that malaria disrupts these pathways leading to preterm birth (PTB). METHODS AND FINDINGS:We conducted a secondary analysis of a randomized trial of malaria prevention in pregnancy conducted in Malawi from July 21, 2011, to March 18, 2013. We longitudinally assessed circulating mediators of angiogenic, metabolic, and inflammatory pathways during pregnancy in a cohort of HIV-negative women (n = 1,628), with a median age of 21 years [18, 25], and 562 (35%) were primigravid. Pregnancies were ultrasound dated, and samples were analyzed at 13 to 23 weeks (Visit 1), 28 to 33 weeks (Visit 2), and/or 34 to 36 weeks (Visit 3). Malaria prevalence was high; 70% (n = 1,138) had PCR-positive Plasmodium falciparum infection at least once over the course of pregnancy and/or positive placental histology. The risk of delivering preterm in the entire cohort was 20% (n = 304/1506). Women with malaria before 24 weeks gestation had a higher risk of PTB (24% versus 18%, p = 0.005; adjusted relative risk [aRR] 1.30, 95% confidence interval [CI] 1.04-1.63, p = 0.021); and those who were malaria positive only before week 24 had an even greater risk of PTB (28% versus 17%, p = 0.02; with an aRR of 1.67, 95% CI 1.20-2.30, p = 0.002). Using linear mixed-effects modeling, malaria before 24 weeks gestation was associated with altered kinetics of inflammatory (C-Reactive Protein [CRP], Chitinase 3-like protein-1 [CHI3L1], Interleukin 18 Binding Protein [IL-18BP], soluble Tumor Necrosis Factor receptor II [sTNFRII], soluble Intercellular Adhesion Molecule-1 [sICAM-1]), angiogenic (soluble Endoglin [sEng]), and metabolic mediators (Leptin, Angiopoietin-like 3 [Angptl3]) over the course of pregnancy (χ2 > 13.0, p ≤ 0.001 for each). Limitations include being underpowered to assess the impact on nonviable births, being unable to assess women who had not received any antimalarials, and, because of the exposure to antimalarials in the second trimester, there were limited numbers of malaria infections late in pregnancy. CONCLUSIONS:Current interventions for the prevention of malaria in pregnancy are initiated at the first antenatal visit, usually in the second trimester. In this study, we found that many women are already malaria-infected by their first visit. Malaria infection before 24 weeks gestation was associated with dysregulation of essential regulators of angiogenesis, metabolism, and inflammation and an increased risk of PTB. Preventing malaria earlier in pregnancy may reduce placental dysfunction and thereby improve birth outcomes in malaria-endemic settings.
first_indexed 2024-12-21T09:16:20Z
format Article
id doaj.art-669bbf685ae747cda33e31edc93cd1d6
institution Directory Open Access Journal
issn 1549-1277
1549-1676
language English
last_indexed 2024-12-21T09:16:20Z
publishDate 2019-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj.art-669bbf685ae747cda33e31edc93cd1d62022-12-21T19:09:09ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762019-10-011610e100291410.1371/journal.pmed.1002914Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.Robyn E ElphinstoneAndrea M WeckmanChloe R McDonaldVanessa TranKathleen ZhongMwayiwawo MadanitsaLinda Kalilani-PhiriCarole KhairallahSteve M TaylorSteven R MeshnickVictor MwapasaFeiko O Ter KuileAndrea L ConroyKevin C KainBACKGROUND:Malaria in pregnancy is associated with adverse birth outcomes. However, the underlying mechanisms remain poorly understood. Tight regulation of angiogenic, metabolic, and inflammatory pathways are essential for healthy pregnancies. We hypothesized that malaria disrupts these pathways leading to preterm birth (PTB). METHODS AND FINDINGS:We conducted a secondary analysis of a randomized trial of malaria prevention in pregnancy conducted in Malawi from July 21, 2011, to March 18, 2013. We longitudinally assessed circulating mediators of angiogenic, metabolic, and inflammatory pathways during pregnancy in a cohort of HIV-negative women (n = 1,628), with a median age of 21 years [18, 25], and 562 (35%) were primigravid. Pregnancies were ultrasound dated, and samples were analyzed at 13 to 23 weeks (Visit 1), 28 to 33 weeks (Visit 2), and/or 34 to 36 weeks (Visit 3). Malaria prevalence was high; 70% (n = 1,138) had PCR-positive Plasmodium falciparum infection at least once over the course of pregnancy and/or positive placental histology. The risk of delivering preterm in the entire cohort was 20% (n = 304/1506). Women with malaria before 24 weeks gestation had a higher risk of PTB (24% versus 18%, p = 0.005; adjusted relative risk [aRR] 1.30, 95% confidence interval [CI] 1.04-1.63, p = 0.021); and those who were malaria positive only before week 24 had an even greater risk of PTB (28% versus 17%, p = 0.02; with an aRR of 1.67, 95% CI 1.20-2.30, p = 0.002). Using linear mixed-effects modeling, malaria before 24 weeks gestation was associated with altered kinetics of inflammatory (C-Reactive Protein [CRP], Chitinase 3-like protein-1 [CHI3L1], Interleukin 18 Binding Protein [IL-18BP], soluble Tumor Necrosis Factor receptor II [sTNFRII], soluble Intercellular Adhesion Molecule-1 [sICAM-1]), angiogenic (soluble Endoglin [sEng]), and metabolic mediators (Leptin, Angiopoietin-like 3 [Angptl3]) over the course of pregnancy (χ2 > 13.0, p ≤ 0.001 for each). Limitations include being underpowered to assess the impact on nonviable births, being unable to assess women who had not received any antimalarials, and, because of the exposure to antimalarials in the second trimester, there were limited numbers of malaria infections late in pregnancy. CONCLUSIONS:Current interventions for the prevention of malaria in pregnancy are initiated at the first antenatal visit, usually in the second trimester. In this study, we found that many women are already malaria-infected by their first visit. Malaria infection before 24 weeks gestation was associated with dysregulation of essential regulators of angiogenesis, metabolism, and inflammation and an increased risk of PTB. Preventing malaria earlier in pregnancy may reduce placental dysfunction and thereby improve birth outcomes in malaria-endemic settings.https://doi.org/10.1371/journal.pmed.1002914
spellingShingle Robyn E Elphinstone
Andrea M Weckman
Chloe R McDonald
Vanessa Tran
Kathleen Zhong
Mwayiwawo Madanitsa
Linda Kalilani-Phiri
Carole Khairallah
Steve M Taylor
Steven R Meshnick
Victor Mwapasa
Feiko O Ter Kuile
Andrea L Conroy
Kevin C Kain
Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
PLoS Medicine
title Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
title_full Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
title_fullStr Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
title_full_unstemmed Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
title_short Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
title_sort early malaria infection dysregulation of angiogenesis metabolism and inflammation across pregnancy and risk of preterm birth in malawi a cohort study
url https://doi.org/10.1371/journal.pmed.1002914
work_keys_str_mv AT robyneelphinstone earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT andreamweckman earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT chloermcdonald earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT vanessatran earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT kathleenzhong earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT mwayiwawomadanitsa earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT lindakalilaniphiri earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT carolekhairallah earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT stevemtaylor earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT stevenrmeshnick earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT victormwapasa earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT feikooterkuile earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT andrealconroy earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy
AT kevinckain earlymalariainfectiondysregulationofangiogenesismetabolismandinflammationacrosspregnancyandriskofpretermbirthinmalawiacohortstudy